{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:13:10Z","timestamp":1772165590653,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T00:00:00Z","timestamp":1714176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T00:00:00Z","timestamp":1714176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Tianjin Health Commission Science and Technology Talent Cultivation Project","award":["RC20184"],"award-info":[{"award-number":["RC20184"]}]},{"name":"Tianjin Health Commission Science and Technology Key Project","award":["ZD20002"],"award-info":[{"award-number":["ZD20002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Unidentified heart failure occurs in patients with multiple myeloma when their heart was involved. CMR with late gadolinium enhancement (LGE) and T1 mapping can identify myocardial amyloid infiltrations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To explore the role of CMR with late gadolinium enhancement (LGE) and T1 mapping for detection of multiple myeloma patients\u2019heart.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and methods<\/jats:title>\n                    <jats:p>\n                      A total of 16 MM patients with above underwent CMR (3.0-T) with T1 mapping (pre-contrast and post-contrast) and LGE imaging. In addition, 26 patients with non-obstructive hypertrophic cardiomyopathy and 26 healthy volunteers were compared to age- and sex-matched healthy controls without a history of cardiac disease, diabetes mellitus, or normal in CMR. All statistical analyses were performed using the statistical software GraphPad Prism. The measurement data were represented by median (X) and single sample T test was adopted. Enumeration data were represented by examples and Chi-tested was adopted. All tests were two-sided, and\n                      <jats:italic>P<\/jats:italic>\n                      values\u2009&lt;\u20090.05 were considered statistically significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In MM group, LVEF was lower than healthy controls and higher than that of non-obstructive hypertrophic cardiomyopathy group, but without statistically significant difference (%: 49.1\u2009\u00b1\u200917.5 vs. 55.6\u2009\u00b1\u200910.3, 40.4\u2009\u00b1\u200915.6, all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&gt;\u20090.05). Pre-contrast T1 values of MM group were obviously higher than those of healthy controls and non-obstructive hypertrophic cardiomyopathy group (ms:1462.0\u2009\u00b1\u200971.3vs. 1269.3\u2009\u00b1\u200942.3, 1324.0\u2009\u00b1\u200945.1, all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). 16 cases (100%) in MM group all had LGE.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>LGE joint T1 mapping wider clinical use techniques and follow-up the patients\u2019disease severity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-024-03895-y","type":"journal-article","created":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T05:01:35Z","timestamp":1714194095000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic value of LGE and T1 mapping in multiple myeloma patients\u2019heart"],"prefix":"10.1186","volume":"24","author":[{"given":"Qian","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xihong","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangfeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,27]]},"reference":[{"key":"3895_CR1","doi-asserted-by":"publisher","unstructured":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis. Circ Cardiovasc Imaging. 2021;14. https:\/\/doi.org\/10.1161\/HCI.0000000000000029.","DOI":"10.1161\/HCI.0000000000000029"},{"key":"3895_CR2","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1056\/NEJMra023144","volume":"349","author":"G Merlini","year":"2003","unstructured":"Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med. 2003;349:583\u201396. https:\/\/doi.org\/10.1056\/NEJMra023144.","journal-title":"N Engl J Med"},{"key":"3895_CR3","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.carpath.2015.07.008","volume":"24","author":"JJ Maleszewski","year":"2015","unstructured":"Maleszewski JJ. Cardiac amyloidosis: pathology, nomenclature, and typing. Cardiovasc Pathol. 2015;24:343\u201350. https:\/\/doi.org\/10.1016\/j.carpath.2015.07.008.","journal-title":"Cardiovasc Pathol"},{"key":"3895_CR4","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1148\/rg.2015140179","volume":"35","author":"F Czeyda-Pommersheim","year":"2015","unstructured":"Czeyda-Pommersheim F, Hwang M, Chen SS, et al. Amyloidosis: modern cross-sectional imaging. Radiographics. 2015;35:1381\u201392. https:\/\/doi.org\/10.1148\/rg.2015140179.","journal-title":"Radiographics"},{"key":"3895_CR5","first-page":"178","volume":"32","author":"W Hassan","year":"2005","unstructured":"Hassan W, Al-Sergani H, Mourad W, et al. Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management. Tex Heart Inst J. 2005;32:178\u201384.","journal-title":"Tex Heart Inst J."},{"key":"3895_CR6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.pcad.2009.11.007","volume":"52","author":"RH Falk","year":"2010","unstructured":"Falk RH, Dubrey SW. Amyloid heart disease. Prog Cardiovasc Dis. 2010;52:347\u201361. https:\/\/doi.org\/10.1016\/j.pcad.2009.11.007.","journal-title":"Prog Cardiovasc Dis"},{"key":"3895_CR7","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","volume":"387","author":"AD Wechalekar","year":"2016","unstructured":"Wechalekar AD, Gillmore JD, Hawkins PN. Systemic amyloidosis. Lancet. 2016;387:2641\u201354. https:\/\/doi.org\/10.1016\/S0140-6736(15)01274-X.","journal-title":"Lancet"},{"key":"3895_CR8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.5114\/reum.2020.101998","volume":"58","author":"K Jamroziak","year":"2020","unstructured":"Jamroziak K, Pula B. Advances in diagnostics and therapy of systemic amyloidoses. Reumatologia. 2020;58:343\u20134. https:\/\/doi.org\/10.5114\/reum.2020.101998.","journal-title":"Reumatologia"},{"key":"3895_CR9","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1161\/01.CIR.0000152819.97857.9D","volume":"111","author":"AM Maceira","year":"2005","unstructured":"Maceira AM, Joshi J, Prasad SK, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2005;111:186\u201393. https:\/\/doi.org\/10.1161\/01.CIR.0000152819.97857.9D.","journal-title":"Circulation"},{"key":"3895_CR10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1532-429X-10-54","volume":"10","author":"AM Maceira","year":"2008","unstructured":"Maceira AM, Prasad SK, Hawkins PN, et al. Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson. 2008;10:54. https:\/\/doi.org\/10.1186\/1532-429X-10-54.","journal-title":"J Cardiovasc Magn Reson"},{"key":"3895_CR11","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jacc.2007.10.049","volume":"51","author":"H Vogelsberg","year":"2008","unstructured":"Vogelsberg H, Mahrholdt H, Deluigi CC, et al. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol. 2008;51:1022\u201330. https:\/\/doi.org\/10.1016\/j.jacc.2007.10.049.","journal-title":"J Am Coll Cardiol"},{"key":"3895_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jcmg.2013.08.015","volume":"7","author":"JN Dungu","year":"2014","unstructured":"Dungu JN, Valencia O, Pinney JH, et al. CMR-based differentiation of AL and ATTR cardiac amyloidosis. JACC Cardiovasc Imaging. 2014;7:133\u201342. https:\/\/doi.org\/10.1016\/j.jcmg.2013.08.015.","journal-title":"JACC Cardiovasc Imaging"},{"key":"3895_CR13","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","volume":"132","author":"M Fontana","year":"2015","unstructured":"Fontana M, Pica S, Reant P, et al. Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2015;132:1570\u20139. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.016567.","journal-title":"Circulation"},{"key":"3895_CR14","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ahj.2008.09.012","volume":"157","author":"M Nigri","year":"2009","unstructured":"Nigri M, Azevedo CF, Rochitte CE, et al. Contrast-enhanced magnetic resonance imaging identifies focal regions of intramyocardial fibrosis in patients with severe aortic valve disease: correlation with quantitative histopathology. Am Heart J. 2009;157:361\u20138. https:\/\/doi.org\/10.1016\/j.ahj.2008.09.012.","journal-title":"Am Heart J"},{"key":"3895_CR15","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1161\/CIRCULATIONAHA.109.930636","volume":"122","author":"AS Flett","year":"2010","unstructured":"Flett AS, Hayward MP, Ashworth MT, et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation. 2010;122:138\u201344. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.930636.","journal-title":"Circulation"},{"key":"3895_CR16","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.jacc.2008.06.049","volume":"52","author":"L Iles","year":"2008","unstructured":"Iles L, Pfluger H, Phrommintikul A, et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol. 2008;52:1574\u201380. https:\/\/doi.org\/10.1016\/j.jacc.2008.06.049.","journal-title":"J Am Coll Cardiol"},{"key":"3895_CR17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jcmg.2013.10.008","volume":"7","author":"M Fontana","year":"2014","unstructured":"Fontana M, Banypersad SM, Treibel TA, et al. Native T1 mapping in transthyretin amyloidosis. JACC Cardiovasc Imaging. 2014;7:157\u201365. https:\/\/doi.org\/10.1016\/j.jcmg.2013.10.008.","journal-title":"JACC Cardiovasc Imaging"},{"key":"3895_CR18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jcmg.2019.03.026","volume":"13","author":"A Baggiano","year":"2020","unstructured":"Baggiano A, Boldrini M, Martinez-Naharro A, et al. Noncontrast magnetic resonance for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging. 2020;13:69\u201380. https:\/\/doi.org\/10.1016\/j.jcmg.2019.03.026.","journal-title":"JACC Cardiovasc Imaging"},{"key":"3895_CR19","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/jmri.25678","volume":"46","author":"A Arani","year":"2017","unstructured":"Arani A, Arunachalam SP, Chang ICY, et al. Cardiac MR elastography for quantitative assessment of elevated myocardial stiffness in cardiac amyloidosis. J Magn Reson Imaging. 2017;46:1361\u20137. https:\/\/doi.org\/10.1002\/jmri.25678.","journal-title":"J Magn Reson Imaging"},{"key":"3895_CR20","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.mric.2019.04.005","volume":"27","author":"FP Carvalho","year":"2019","unstructured":"Carvalho FP, Erthal F, Azevedo CF. The role of cardiac MR imaging in the assessment of patients with cardiac amyloidosis. Magn Reson Imaging Clin N Am. 2019;27:453\u201363. https:\/\/doi.org\/10.1016\/j.mric.2019.04.005.","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"3895_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1161\/CIRCIMAGING.112.978627","volume":"6","author":"SM Banypersad","year":"2013","unstructured":"Banypersad SM, Sado DM, Flett AS, et al. Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study. Circ Cardiovasc Imaging. 2013;6:34\u20139. https:\/\/doi.org\/10.1161\/CIRCIMAGING.112.978627.","journal-title":"Circ Cardiovasc Imaging"},{"key":"3895_CR22","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1136\/heartjnl-2012-303052","volume":"99","author":"S Bull","year":"2013","unstructured":"Bull S, White SK, Piechnik SK, et al. Human non-contrast T1 values and correlation with histology in diffuse fibrosis. Heart. 2013;99:932\u20137. https:\/\/doi.org\/10.1136\/heartjnl-2012-303052.","journal-title":"Heart"},{"key":"3895_CR23","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.104.489187","volume":"112","author":"RH Falk","year":"2005","unstructured":"Falk RH. Diagnosis and management of the cardiac amyloidoses. Circulation. 2005;112:2047\u201360. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.104.489187.","journal-title":"Circulation"},{"key":"3895_CR24","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1146\/annurev-biochem-072611-130030","volume":"82","author":"LM Blancas-Mejia","year":"2013","unstructured":"Blancas-Mejia LM, Ramirez-Alvarado M. Systemic amyloidoses. Annu Rev Biochem. 2013;82:745\u201374. https:\/\/doi.org\/10.1146\/annurev-biochem-072611-130030.","journal-title":"Annu Rev Biochem"},{"key":"3895_CR25","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1002\/jmri.20917","volume":"25","author":"GA Krombach","year":"2007","unstructured":"Krombach GA, Hahn C, Tomars M, et al. Cardiac amyloidosis: MR imaging findings and T1 quantification, comparison with control subjects. J Magn Reson Imaging. 2007;25:1283\u20137. https:\/\/doi.org\/10.1002\/jmri.20917.","journal-title":"J Magn Reson Imaging"},{"key":"3895_CR26","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1001\/archinte.165.12.1425","volume":"165","author":"B Ng","year":"2005","unstructured":"Ng B, Connors LH, Davidoff R, et al. Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis. Arch Intern Med. 2005;165:1425\u20139. https:\/\/doi.org\/10.1001\/archinte.165.12.1425.","journal-title":"Arch Intern Med"},{"key":"3895_CR27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcmg.2009.09.023","volume":"3","author":"IS Syed","year":"2010","unstructured":"Syed IS, Glockner JF, Feng D, et al. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. JACC Cardiovasc Imaging. 2010;3:155\u201364. https:\/\/doi.org\/10.1016\/j.jcmg.2009.09.023.","journal-title":"JACC Cardiovasc Imaging"},{"key":"3895_CR28","doi-asserted-by":"publisher","first-page":"e000098","DOI":"10.1161\/jaha.113.000098","volume":"2","author":"JH Pinney","year":"2013","unstructured":"Pinney JH, Whelan CJ, Petrie A, et al. Senile systemic amyloidosis: clinical features at presentation and outcome. J Am Heart Assoc. 2013;2:e000098. https:\/\/doi.org\/10.1161\/jaha.113.000098.","journal-title":"J Am Heart Assoc"},{"key":"3895_CR29","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.jcmg.2012.11.013","volume":"6","author":"TD Karamitsos","year":"2013","unstructured":"Karamitsos TD, Piechnik SK, Banypersad SM, et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging. 2013;6:488\u201397. https:\/\/doi.org\/10.1016\/j.jcmg.2012.11.013.","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-03895-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-024-03895-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-03895-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T05:03:01Z","timestamp":1714194181000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-024-03895-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,27]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3895"],"URL":"https:\/\/doi.org\/10.1186\/s12872-024-03895-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3147494\/v1","asserted-by":"object"}]},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,27]]},"assertion":[{"value":"7 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The approval for the study was taken by Tianjin First Center Hospital licensing committee IRB and informed consent was obtained from all subjects and\/or their legal guardian all methods were carried out in accordance with relevant guidelines and regulations(declaration of helsinki), Written Informed Consent.Institutional Review Board approval was obtained.Review date: Aug,8th,2020.Review number:2020N077KY.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Our manuscript does not include any revealing information about participants. Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"230"}}